Report Detail

Request for Sample of this report

Chemical & Material Global Recombinant Brazzein Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4671716
    • |
  • 10 February, 2026
    • |
  • Global
    • |
  • 116 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Recombinant Brazzein market size was valued at US$ 187 million in 2025 and is forecast to a readjusted size of US$ 315 million by 2032 with a CAGR of 7.7% during review period.
Brazzein, a naturally derived sweet protein, was first isolated from the fruit of the tropical West African plant *Pentadiplandra brazzeana*. Its sweetness is 500 to 2,000 times that of sucrose, making it one of the most potent natural sweet proteins known. Through modern recombinant DNA technology, it can be expressed and produced in microorganisms or engineered bacteria (such as yeast and bacteria), giving this high-sweetness protein the potential for large-scale commercialization. Compared to traditional artificial sweeteners, Brazzein, a protein-based sweetener, is low in calories, thermally stable, pH stable, non-bitter, and readily water-soluble. It maintains its sweetness during food processing, providing a natural sweetening solution for low-sugar or sugar-free foods. With a molecular weight of approximately 6.5 kDa, its extremely high sweetness intensity, and taste close to sucrose, makes it a promising alternative sweetener in the food industry, particularly in beverages, confectionery, pastries, and nutritional foods. In 2024, global production of Recombinant Brazzein reached 403.11 tons, with an average selling price of $450/kg. Production volume is significantly lower than traditional sweeteners and is primarily driven by a few synthetic biotechnology companies, with a gross profit margin of approximately 35%–55%.
Currently, the strains used for research and production of brassin mainly include: *E. coli*, yeast, *Pichia pastoris*, *Aspergillus oryzae* host expression, and recombinant *Trichoderma reesei* strains. The challenges to its industrialization lie in the problems of current microbial expression systems (such as *E. coli* and fungi), such as low protein expression levels, protein misfolding leading to reduced activity, and complex and costly purification processes. All of these factors limit the widespread application of sweet proteins. Key advancements in the development of brazzein in the industry include:
In May 2023, California-based food ingredient startup Sweeten successfully produced the super-sweet protein Brazzein using precision fermentation technology, becoming the first company to receive FEMA GRAS (Generally Recognized As Safe, GRAS) certification.
In 2024, Oobli, a US-based company, successfully obtained FDA GRAS certification for its brazzein produced using precision fermentation technology, allowing it to be used in food and beverages. In February 2025, Oobli announced a collaboration with sweetener giant Ingredion to advance the sweetener applications of brazzein.
In May 2024, synthetic biology leader Ginkgo Bioworks partnered with GreenLab to work on improving the expression of brazzein in corn kernels and utilizing precision fermentation technology to achieve commercial-scale production of brazzein.
In March 2025, Waterdrop Agriculture also received FDA SELF-GRAS certification, becoming one of the few companies globally to achieve commercialization. And we are selling to countries and regions that accept this certification. Currently, we are promoting our products in the United States, Latin America, and Southeast Asia.
This report is a detailed and comprehensive analysis for global Recombinant Brazzein market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Brazzein market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Recombinant Brazzein market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Recombinant Brazzein market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Recombinant Brazzein market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Brazzein
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Brazzein market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Oobli, Ingredion, Sweegen, Amai Protein, Novel Foods Group, Perfect Day, Amai Proteins, MycoTechnology, Nomad Bioscience GmbH, Naturannova, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Brazzein market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity 90%-95%
Purity greater than 95%
Market segment by Channel
Commercial Use
Home Use
Market segment by Sales
Direct Selling
Distribution
Market segment by Application
Dairy Products
Baking
Dietary Supplements
Beverages
Others
Major players covered
Oobli
Ingredion
Sweegen
Amai Protein
Novel Foods Group
Perfect Day
Amai Proteins
MycoTechnology
Nomad Bioscience GmbH
Naturannova
Ajinomoto Health & Nutrition
BRAIN AG（AnalytiCon Discovery）
Aquafarmtory
Bestzyme
Gdzhumei
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Brazzein product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Brazzein, with price, sales quantity, revenue, and global market share of Recombinant Brazzein from 2021 to 2026.
Chapter 3, the Recombinant Brazzein competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Brazzein breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Recombinant Brazzein market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Brazzein.
Chapter 14 and 15, to describe Recombinant Brazzein sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Recombinant Brazzein Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity 90%-95%
    • 1.3.3 Purity greater than 95%
  • 1.4 Market Analysis by Channel
    • 1.4.1 Overview: Global Recombinant Brazzein Consumption Value by Channel: 2021 Versus 2025 Versus 2032
    • 1.4.2 Commercial Use
    • 1.4.3 Home Use
  • 1.5 Market Analysis by Sales
    • 1.5.1 Overview: Global Recombinant Brazzein Consumption Value by Sales: 2021 Versus 2025 Versus 2032
    • 1.5.2 Direct Selling
    • 1.5.3 Distribution
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Recombinant Brazzein Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Dairy Products
    • 1.6.3 Baking
    • 1.6.4 Dietary Supplements
    • 1.6.5 Beverages
    • 1.6.6 Others
  • 1.7 Global Recombinant Brazzein Market Size & Forecast
    • 1.7.1 Global Recombinant Brazzein Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Recombinant Brazzein Sales Quantity (2021-2032)
    • 1.7.3 Global Recombinant Brazzein Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Oobli
    • 2.1.1 Oobli Details
    • 2.1.2 Oobli Major Business
    • 2.1.3 Oobli Recombinant Brazzein Product and Services
    • 2.1.4 Oobli Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Oobli Recent Developments/Updates
  • 2.2 Ingredion
    • 2.2.1 Ingredion Details
    • 2.2.2 Ingredion Major Business
    • 2.2.3 Ingredion Recombinant Brazzein Product and Services
    • 2.2.4 Ingredion Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Ingredion Recent Developments/Updates
  • 2.3 Sweegen
    • 2.3.1 Sweegen Details
    • 2.3.2 Sweegen Major Business
    • 2.3.3 Sweegen Recombinant Brazzein Product and Services
    • 2.3.4 Sweegen Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sweegen Recent Developments/Updates
  • 2.4 Amai Protein
    • 2.4.1 Amai Protein Details
    • 2.4.2 Amai Protein Major Business
    • 2.4.3 Amai Protein Recombinant Brazzein Product and Services
    • 2.4.4 Amai Protein Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Amai Protein Recent Developments/Updates
  • 2.5 Novel Foods Group
    • 2.5.1 Novel Foods Group Details
    • 2.5.2 Novel Foods Group Major Business
    • 2.5.3 Novel Foods Group Recombinant Brazzein Product and Services
    • 2.5.4 Novel Foods Group Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Novel Foods Group Recent Developments/Updates
  • 2.6 Perfect Day
    • 2.6.1 Perfect Day Details
    • 2.6.2 Perfect Day Major Business
    • 2.6.3 Perfect Day Recombinant Brazzein Product and Services
    • 2.6.4 Perfect Day Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Perfect Day Recent Developments/Updates
  • 2.7 Amai Proteins
    • 2.7.1 Amai Proteins Details
    • 2.7.2 Amai Proteins Major Business
    • 2.7.3 Amai Proteins Recombinant Brazzein Product and Services
    • 2.7.4 Amai Proteins Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Amai Proteins Recent Developments/Updates
  • 2.8 MycoTechnology
    • 2.8.1 MycoTechnology Details
    • 2.8.2 MycoTechnology Major Business
    • 2.8.3 MycoTechnology Recombinant Brazzein Product and Services
    • 2.8.4 MycoTechnology Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 MycoTechnology Recent Developments/Updates
  • 2.9 Nomad Bioscience GmbH
    • 2.9.1 Nomad Bioscience GmbH Details
    • 2.9.2 Nomad Bioscience GmbH Major Business
    • 2.9.3 Nomad Bioscience GmbH Recombinant Brazzein Product and Services
    • 2.9.4 Nomad Bioscience GmbH Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Nomad Bioscience GmbH Recent Developments/Updates
  • 2.10 Naturannova
    • 2.10.1 Naturannova Details
    • 2.10.2 Naturannova Major Business
    • 2.10.3 Naturannova Recombinant Brazzein Product and Services
    • 2.10.4 Naturannova Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Naturannova Recent Developments/Updates
  • 2.11 Ajinomoto Health & Nutrition
    • 2.11.1 Ajinomoto Health & Nutrition Details
    • 2.11.2 Ajinomoto Health & Nutrition Major Business
    • 2.11.3 Ajinomoto Health & Nutrition Recombinant Brazzein Product and Services
    • 2.11.4 Ajinomoto Health & Nutrition Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Ajinomoto Health & Nutrition Recent Developments/Updates
  • 2.12 BRAIN AG（AnalytiCon Discovery）
    • 2.12.1 BRAIN AG（AnalytiCon Discovery） Details
    • 2.12.2 BRAIN AG（AnalytiCon Discovery） Major Business
    • 2.12.3 BRAIN AG（AnalytiCon Discovery） Recombinant Brazzein Product and Services
    • 2.12.4 BRAIN AG（AnalytiCon Discovery） Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 BRAIN AG（AnalytiCon Discovery） Recent Developments/Updates
  • 2.13 Aquafarmtory
    • 2.13.1 Aquafarmtory Details
    • 2.13.2 Aquafarmtory Major Business
    • 2.13.3 Aquafarmtory Recombinant Brazzein Product and Services
    • 2.13.4 Aquafarmtory Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Aquafarmtory Recent Developments/Updates
  • 2.14 Bestzyme
    • 2.14.1 Bestzyme Details
    • 2.14.2 Bestzyme Major Business
    • 2.14.3 Bestzyme Recombinant Brazzein Product and Services
    • 2.14.4 Bestzyme Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Bestzyme Recent Developments/Updates
  • 2.15 Gdzhumei
    • 2.15.1 Gdzhumei Details
    • 2.15.2 Gdzhumei Major Business
    • 2.15.3 Gdzhumei Recombinant Brazzein Product and Services
    • 2.15.4 Gdzhumei Recombinant Brazzein Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Gdzhumei Recent Developments/Updates

3 Competitive Environment: Recombinant Brazzein by Manufacturer

  • 3.1 Global Recombinant Brazzein Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Recombinant Brazzein Revenue by Manufacturer (2021-2026)
  • 3.3 Global Recombinant Brazzein Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Recombinant Brazzein by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Recombinant Brazzein Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Recombinant Brazzein Manufacturer Market Share in 2025
  • 3.5 Recombinant Brazzein Market: Overall Company Footprint Analysis
    • 3.5.1 Recombinant Brazzein Market: Region Footprint
    • 3.5.2 Recombinant Brazzein Market: Company Product Type Footprint
    • 3.5.3 Recombinant Brazzein Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Recombinant Brazzein Market Size by Region
    • 4.1.1 Global Recombinant Brazzein Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Recombinant Brazzein Consumption Value by Region (2021-2032)
    • 4.1.3 Global Recombinant Brazzein Average Price by Region (2021-2032)
  • 4.2 North America Recombinant Brazzein Consumption Value (2021-2032)
  • 4.3 Europe Recombinant Brazzein Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Recombinant Brazzein Consumption Value (2021-2032)
  • 4.5 South America Recombinant Brazzein Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Recombinant Brazzein Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Recombinant Brazzein Sales Quantity by Type (2021-2032)
  • 5.2 Global Recombinant Brazzein Consumption Value by Type (2021-2032)
  • 5.3 Global Recombinant Brazzein Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Recombinant Brazzein Sales Quantity by Application (2021-2032)
  • 6.2 Global Recombinant Brazzein Consumption Value by Application (2021-2032)
  • 6.3 Global Recombinant Brazzein Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Recombinant Brazzein Sales Quantity by Type (2021-2032)
  • 7.2 North America Recombinant Brazzein Sales Quantity by Application (2021-2032)
  • 7.3 North America Recombinant Brazzein Market Size by Country
    • 7.3.1 North America Recombinant Brazzein Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Recombinant Brazzein Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Recombinant Brazzein Sales Quantity by Type (2021-2032)
  • 8.2 Europe Recombinant Brazzein Sales Quantity by Application (2021-2032)
  • 8.3 Europe Recombinant Brazzein Market Size by Country
    • 8.3.1 Europe Recombinant Brazzein Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Recombinant Brazzein Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Recombinant Brazzein Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Recombinant Brazzein Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Recombinant Brazzein Market Size by Region
    • 9.3.1 Asia-Pacific Recombinant Brazzein Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Recombinant Brazzein Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Recombinant Brazzein Sales Quantity by Type (2021-2032)
  • 10.2 South America Recombinant Brazzein Sales Quantity by Application (2021-2032)
  • 10.3 South America Recombinant Brazzein Market Size by Country
    • 10.3.1 South America Recombinant Brazzein Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Recombinant Brazzein Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Recombinant Brazzein Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Recombinant Brazzein Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Recombinant Brazzein Market Size by Country
    • 11.3.1 Middle East & Africa Recombinant Brazzein Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Recombinant Brazzein Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Recombinant Brazzein Market Drivers
  • 12.2 Recombinant Brazzein Market Restraints
  • 12.3 Recombinant Brazzein Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Recombinant Brazzein and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Recombinant Brazzein
  • 13.3 Recombinant Brazzein Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Recombinant Brazzein Typical Distributors
  • 14.3 Recombinant Brazzein Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Recombinant Brazzein. Industry analysis & Market Report on Recombinant Brazzein is a syndicated market report, published as Global Recombinant Brazzein Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Recombinant Brazzein market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo